Acquisitions5 Jan 2026, 10:01 pm
Biocon Ltd Completes Acquisition of Biocon Biologics Limited Shares for USD 200 Million
AI Summary
Biocon Ltd has completed the acquisition of 7,18,34,691 equity shares of Biocon Biologics Limited from Mylan Inc. for a cash consideration of USD 200 million. This acquisition is part of the total acquisition of 14,36,69,382 equity shares of Biocon Biologics Limited from Mylan Inc. for a cash consideration of USD 400 million, which was approved by the Board on December 06, 2025. Post this acquisition, Biocon Ltd holds approximately 94% of the paid-up equity share capital of Biocon Biologics Limited on a fully diluted basis.
Key Highlights
- Biocon Ltd completes acquisition of 7,18,34,691 equity shares of Biocon Biologics Limited from Mylan Inc. for USD 200 million.
- This acquisition is part of the total acquisition of 14,36,69,382 equity shares of Biocon Biologics Limited from Mylan Inc. for USD 400 million.
- Post acquisition, Biocon Ltd holds approximately 94% of the paid-up equity share capital of Biocon Biologics Limited on a fully diluted basis.
- The acquisition was completed on January 05, 2026.
- Biocon Ltd has issued and allotted 17,12,79,553 equity shares of the Company as consideration for the acquisition.